Manjunath Mallaya Jayawanth
Department of Biochemistry and Nutrition, CSIR- Central Food Technological Research Institute (CFTRI), Mysore - 570020, India.
Cent Nerv Syst Agents Med Chem. 2013 Mar;13(1):43-56. doi: 10.2174/1871524911313010007.
Withania somnifera (WS) an ayurvedic medicinal herb is widely known for its memory enhancing ability and improvement of brain function. In the present study, we tested the hypothesis that WS prophylaxis could offset neurotoxicant-induced oxidative dysfunctions in developing brain employing a rotenone (ROT) mouse model. Initially, we assessed the potential of WS oral supplements (100-400 mg/ kg b.w/ d, 4wks) to modulate the endogenous levels of oxidative markers in cerebellum (cb) and striatum (st) of prepubertal (PP) mice. Further, we assessed the induction of oxidative stress in cb and st of mice administered with ROT (i.p. 0.5 and 1mg/ kg b.w, 7d). ROT caused significant elevation in the levels of reactive oxygen species (ROS), malondialdehyde (MDA), hydroperoxides (HP) and nitric oxide (NO) levels in both brain regions. Further ROT caused significant perturbations in the levels of reduced glutathione (GSH), activity levels of antioxidant enzymes, acetylcholinesterase and mitochondrial dysfunctions suggesting a state of oxidative stress. In a satellite study, we examined the protective effects of WS root powder (400mg/ kg b.w/ d, 4wks) in PP mice challenged with ROT (0.5 mg/ kg b.w/ d, 7 d). WS prophylaxis significantly offset ROT-induced oxidative damage in st and cb as evident by the normalized levels of oxidative markers (MDA, ROS levels and HP) and restoration of depleted GSH levels. Further, WS effectively normalized the NO levels in both brain regions suggesting its antiinflammatory action. Furthermore, WS prophylaxis restored the activity levels of cytosolic antioxidant enzymes, neurotransmitter function and dopamine levels in st. Taken together, these findings suggest that WS prophylaxis has the propensity to modulate neurotoxicant-mediated oxidative impairments and mitochondrial dysfunctions in specific brain regions of mice. While the exact mechanism/s underlying the neuroprotective effects of WS merit further investigation, based on our findings, we hypothesize that it may be wholly or in part due to its ability to enhance GSH, thiols and antioxidant defences in the brain of mice.
印度人参(WS)是一种阿育吠陀草药,以其增强记忆力和改善脑功能的能力而广为人知。在本研究中,我们采用鱼藤酮(ROT)小鼠模型,检验了印度人参预防可抵消发育中大脑神经毒物诱导的氧化功能障碍这一假设。最初,我们评估了印度人参口服补充剂(100 - 400毫克/千克体重/天,4周)调节青春期前(PP)小鼠小脑(cb)和纹状体(st)中氧化标志物内源性水平的潜力。此外,我们评估了给予ROT(腹腔注射0.5和1毫克/千克体重,7天)的小鼠cb和st中氧化应激的诱导情况。ROT导致两个脑区活性氧(ROS)、丙二醛(MDA)、氢过氧化物(HP)和一氧化氮(NO)水平显著升高。此外,ROT导致还原型谷胱甘肽(GSH)水平、抗氧化酶活性水平、乙酰胆碱酯酶和线粒体功能障碍出现显著紊乱,表明存在氧化应激状态。在一项附属研究中,我们研究了印度人参根粉(400毫克/千克体重/天,4周)对用ROT(0.5毫克/千克体重/天,7天)攻击的PP小鼠的保护作用。印度人参预防显著抵消了ROT诱导的st和cb中的氧化损伤,氧化标志物(MDA、ROS水平和HP)水平正常化以及耗尽的GSH水平恢复就证明了这一点。此外,印度人参有效使两个脑区的NO水平正常化,表明其具有抗炎作用。此外,印度人参预防恢复了st中胞质抗氧化酶的活性水平、神经递质功能和多巴胺水平。综上所述,这些发现表明印度人参预防有调节小鼠特定脑区神经毒物介导的氧化损伤和线粒体功能障碍的倾向。虽然印度人参神经保护作用的确切机制值得进一步研究,但根据我们的发现,我们推测这可能全部或部分归因于其增强小鼠大脑中GSH、硫醇和抗氧化防御的能力。